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Abstract
Objectives Liver volumetry has emerged as an important
tool in clinical practice. Liver volume is assessed pri-
marily via organ segmentation of computed tomography
(CT) and magnetic resonance imaging (MRI) images.
The goal of this paper is to provide an accessible over-
view of liver segmentation targeted at radiologists and
other healthcare professionals.
Methods Using images from CT and MRI, this paper reviews
the indications for liver segmentation, technical approaches
used in segmentation software and the developing roles of
liver segmentation in clinical practice.
Results Liver segmentation for volumetric assessment is indi-
cated prior to major hepatectomy, portal vein embolisation,
associating liver partition and portal vein ligation for staged
hepatectomy (ALPPS) and transplant. Segmentation software
can be categorised according to amount of user input in-
volved: manual, semi-automated and fully automated.
Manual segmentation is considered the Bgold standard^ in
clinical practice and research, but is tedious and time-consum-
ing. Increasingly automated segmentation approaches are
more robust, but may suffer from certain segmentation pitfalls.
Emerging applications of segmentation include surgical plan-
ning and integration with MRI-based biomarkers.
Conclusions Liver segmentation has multiple clinical appli-
cations and is expanding in scope. Clinicians can employ
semi-automated or fully automated segmentation options to
more efficiently integrate volumetry into clinical practice.
Teaching points
• Liver volume is assessed via organ segmentation on CTand
MRI examinations.
• Liver segmentation is used for volume assessment prior to
major hepatic procedures.
• Segmentation approaches may be categorised according to
the amount of user input involved.
• Emerging applications include surgical planning and inte-
gration with MRI-based biomarkers.
Keywords Liver . Segmentation . Volumetry . Automated .
Computed tomography .Magnetic resonance imaging
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Introduction
Segmentation refers to the process of delineating an organ of
interest—typically on multiplanar computed tomography
(CT) or magnetic resonance imaging (MRI)—for volumetric
or morphological analysis. The liver is one of the most diffi-
cult organs to segment due to its highly variable shape and
close proximity to other organs. In addition, the liver is subject
to diverse pathologies that may modify its density, signal in-
tensity or distort its architecture. Examples include liver fat,
iron deposits, fibrosis and tumours.
Although physical examination has long been used to de-
tect liver size [1], the variability of liver sizes among patients
limits its ability to detect pathology. As seen in Fig. 1, livers of
similar cranial-caudal length may have markedly different
volumes. Standard liver volumes can be calculated from the
patient’s body surface area or mass using the formulas pro-
posed by Vauthey et al. [2] in 2000. However, these formulas
are limited by subject demographics (healthy individuals) and
by their modest correlation to liver sizes calculated by more
advanced forms of volumetry [3].
The era of modern imaging technology has offered new and
more accurate tools to estimate liver volume. CT volumetry of
the liver was first performed on cadavers by Heymsfield et al.
[4] in 1979 and was shown to be accurate within 5% of water
displacement volumetry. Today, liver volume can be calculated
from both CT and MRI examinations. CT is more commonly
used due to its greater accessibility, higher spatial resolution,
robustness and short acquisition time [5–7]. MRI, conversely,
offers multiple contrast mechanisms and the ability to assess
vascular and biliary anatomy in addition to parenchymal pa-
thology [8]. MRI also minimises the risk of nephrotoxicity and
eliminates concerns of radiation exposure [8].
Liver segmentation has emerged as the preferred technique
of liver volumetry. Liver segmentation involves identifying the
voxels belonging to liver parenchyma on CT or MRI images
via the generation of multiple segments. There are many ap-
proaches to segmentation that involve varying amounts of op-
erator input, each with their own advantages and disadvantages.
The goal of this paper is to provide clinicians with an ac-
cessible primer for liver segmentation. We will first discuss
the major indications for performing liver segmentation for
volumetry. Next, we will provide an overview of the various
segmentation techniques available. Finally, we will discuss
the emerging clinical applications of liver segmentation.
Indications for liver volumetry
Future liver volume prior to major hepatectomy
Liver volumetry is indicated in patients undergoing major
hepatic resection [9], defined as resection of four or more
segments according to the Couinaud classification [10].
Most hepatectomies are performed for the treatment of neo-
plasms, including primary liver cancer (e.g. hepatocellular
carcinoma and cholangiocarcinoma), liver metastases (e.g.
from colorectal cancer) or certain benign tumours (e.g. giant
haemangioma, adenoma, cystadenoma) [11]. Hepatectomies
may also be performed for the management of localised ab-
scesses (pyogenic, amoebic) or after trauma to the liver or
biliary system. Different types of major hepatectomies—in-
cluding left and right complete and extended hepatecto-
mies—are outlined in Fig. 2 [12, 13]. There has been a recent
rise in the number of extended hepatectomies being performed
as definitions of resectability have expanded; extended right
hepatectomies are currently the most common form of hepa-
tectomy, representing 70% of all hepatectomies [14, 15].
Liver volumetry is a useful clinical tool for patients—both
with and without underlying liver disease—undergoing major
hepatic resection [14, 16]. The total liver volume (TLV) and
the future liver remnant (FLR)—the amount of liver that
would be left post-resection—are measured. FLR volume
has been shown to be an indicator of both post-operative liver
function and clinical outcome; it is also one of the only inde-
pendent predictors of post-operative liver dysfunction [14].
In patients with otherwise normal livers, the FLR/TLVratio
should be >20%; in patients with moderately diseased liver,
the ratio should be >30%; finally, in patients with cirrhosis or
fibrosis, the ratio should >40% (Fig. 3) [17]. Moderate liver
disease has been defined as liver steatosis secondary to exten-
sive chemotherapy. Certain systemic chemotherapies directly
induce hepatic steatosis and sinusoidal obstruction syndromes
resulting in fatty liver parenchyma [1]. The extent of the liver
Fig. 1 Variability of liver shape and size. Livers of different shape and
volume may have similar cranial-caudal length, as demonstrated with
these examples of three different patients. This observation highlights
the limitation of reporting a one-dimensional measure of length, a well-
entrenched practice, as a surrogate measure of liver volume
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pathology may be related to other patient specific factors such
as obesity, diabetes and presence of metabolic syndrome [2].
These factors may also impact a given patient’s tolerance of
surgery. Therefore, the aforementioned limits should be
viewed as somewhat flexible. An example of FLR/TLV ratio
calculation prior to hepatectomy and the post-operative result
is demonstrated in Fig. 4 for a normal liver. Patients who are
not candidates for hepatectomy based upon the aforemen-
tioned criteria are at increased risk for post-operative liver
dysfunction and may undergo pre-operative portal vein embo-
lisation (PVE).
Portal vein embolisation (PVE)
Portal vein embolisation (PVE) is performed by an interven-
tional radiologist prior to major hepatectomy to maximise vi-
able FLR. In PVE, portal vein branches that supply liver seg-
ments to be removed during hepatectomy are embolised. This
results in the redistribution of blood flow towards the non-
embolised segments, promoting liver hypertrophy and
increasing anticipated FLR. Patients who have undergone
PVE demonstrate improved liver function post-extended hep-
atectomy compared to patients who have not [2, 16].
PVE is indicated when an increased post-hepatectomy FLR
volume is required for adequate post-operative hepatic func-
tion. This may be due to underlying liver disease or the extent
of the resection planned. Individuals who are expected to have
suboptimal FLR/TLV ratios (as per Fig. 3) are candidates for
PVE [17]. Liver volumetry is generally re-performed 3–
4 weeks post-PVE to assess the extent of hypertrophy of the
FLR prior to surgery [16]. Patients who have reached a
standardised FLR (FLR divided by total liver volume as cal-
culated using the Vauthey equations) of 20% or a degree of
hypertrophy of 5% by this time have more favourable post-
hepatectomy outcomes [18]. However, evidence has emerged
that an increase in liver function—as measured by 99mTc-la-
belled mebrofenin HBS with single photon emission tomog-
raphy—may precede the increase in FLR [19]. Furthermore,
the rate of hypertrophy (not just the degree) may also be an
important indicator of pre-operative readiness [20]. This may
Fig. 2 Types of major
hepatectomy. White segments are
planned for surgical resection. a
Complete right hepatectomy. b
Extended right hepatectomy. c
Complete left hepatectomy. d
Extended left hepatectomy.
Figure adapted from the Brisbane
2000 Terminology of Liver
Anatomy and Resections [12, 13]
Fig. 3 Schematic of functional
liver remnant (FLR) over total
liver volume (TLV) ratio prior to
hepatectomy. To be considered
safely resectable prior to hepatec-
tomy, the FLR/TLV ratio must be
>20% in underlying normal
livers, >30% in moderately dis-
eased livers and >40% in cirrhotic
livers
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explain why certain patients may tolerate hepatectomy earlier
than 3 weeks post-PVE. On the other hand, other practitioners
recommend waiting up to 6 weeks [21]. An example of a
patient who underwent PVE prior to right hepatectomy is
shown in Fig. 5.
Associating liver partition and portal vein ligation
for staged hepatectomy (ALPPS)
In patients with more extensive, rapidly expanding, or bilobar
disease, associating liver partition and portal vein ligation for
staged hepatectomy (ALPPS) has gained popularity. ALPPS
is as two-staged surgical procedure that may offer rapid and
major FLR hypertrophy and a decreased risk of post-operative
liver failure compared to PVE followed by hepatectomy [22];
however, it is also associated with greater peri-operative mor-
bidity and mortality [23].
In the first stage of the procedure, a total resection of tu-
mours from the future FLR is performed (if applicable),
followed by ligation of the portal vein that supplies the liver
to be removed and transection of the liver parenchyma. Both
the FLR and remaining segments are left in situ; the arterial
and biliary systems belonging to the portion of the liver to be
removed are preserved for synthetic function and to avoid
liver necrosis before the second stage. After sufficient hyper-
trophy of the FLR is achieved (generally within 1 week), the
abdomen is reopened for the second stage and the deportalised
liver is removed [24].
Liver volumetry is performed prior to each stage of the
procedure. ALPPS is indicated based on anticipated FLR vol-
ume: in general, the procedure may be offered when pre-
operative volumetry predicts an insufficient FLR associated
with major liver tumour and/or additional liver pathology (in-
cluding chemotherapy-induced damage, fibrosis, cholestasis
or macrosteatosis) [25]. Volumetry is repeated prior to the
second stage to ensure sufficient FLR hypertrophy; a 30%
standardised FLR based on the Vauthey equations is generally
expected before proceeding to the second stage (although
greater hypertrophy has been noted in the literature) [22, 25].
Pre-transplant volumetry
Living-donor liver transplants are increasingly being per-
formed given the rising demand for transplant and the
diminishing availability of cadaveric livers [26]. As such, op-
portunities are being sought to improve donor and recipient
outcomes. In the paediatric recipient population, for example,
it has been shown that transplant of the just the left lateral
segment from a living adult donor is sufficient for adequate
recipient liver function; however, this is not the case in the
adult recipient population [27].
Pre-transplant volumetry is indicated to ensure appropriate
graft size for successful donor and recipient outcomes. To
optimise donor graft survival, an FLR/TLV ratio of 30–40%
is recommended [28, 29]. The ratio of graft size to standard
liver volume (from body surface area) of the recipient should
Fig. 4 Future liver remnant
volume calculation in normal
liver prior to right hepatectomy. a
Axial enhanced CT image
showing colorectal liver
metastasis involving right
posterior segments (VI and VII).
b Resection diagram shows the
intended complete right
hepatectomy surgery planned. c
Three-dimensional rendered im-
age showing surgical planning for
complete right hepatectomy.
FLR/TLV ratio was estimated to
be 33%. d Axial unenhanced CT
image of the same patient shortly
after complete right hepatectomy.
Actual FLR/TLV ratio was calcu-
lated to be 36%. Figure courtesy
of Dr. Vandenbroucke-Menu;
created with 3DVSP (IRCAD,
Strasbourg, France)
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be over 50% [30]; alternatively the ratio of graft size to body
weight of the recipient should be over 0.8–1.0%. Inadequately
sized grafts may be functionally insufficient and may result in
small-for-size syndrome, a potentially fatal condition of he-
patic insufficiency that may require re-transplant [31]. Small-
for-size syndrome is multifactorial, however, and may devel-
op even when appropriate pre-operative volumetry is per-
formed (see Fig. 6).
In the case of right-lobe liver donor transplantation, there is
a dilemma surrounding the inclusion of the middle hepatic
vein (MHV) in the donated graft. The inclusion of the MHV
in the graft is required for adequate venous drainage in the
recipient, but may lead to congestion of segment IV in the
donor liver [32]. To strike a balance, the MHV is therefore
usually transected proximal to a major segment IVb hepatic
vein. This makes pre-operative volumetry along with vascular
assessment advantageous for positive patient outcomes.
Please see the BVascular subsegmentation^ section for further
information.
Segmentation techniques
In this section, the workflow of manual, semi-automated, and
fully automated segmentation strategies will be described
(Fig. 7), with a summary of the strengths and limitations of
each technique.
Manual segmentation
Manual liver segmentation relies heavily on user-
interaction to perform segmentation. Manual segmenta-
tion is performed via the contouring of pixels along the
boundary of the liver or the in-painting of the liver
parenchyma on sequential CT or MR slices. Once the
liver has been identified on each slice, post-processing
software is used to generate liver volume. Early manual
segmentation approaches used very basic tools such as a
pencil, spline widget or paintbrush. Newer manual tech-
niques use algorithms to optimise contouring or in-
painting; despite this rudimentary level of automation,
these techniques may still be considered manual.
To performmanual segmentation via contouring, axial CTor
MR images are saved as Digital Imaging and Communications
in Medicine (DICOM) files and loaded to post-processing soft-
ware. The image analyst then uses a cursor to position nodes
along the liver boundary (see Fig. 8a or the supplementary
material for an animation). Vessels enclosed by the paren-
chyma are included, while those that are adjacent to the
liver—such as the portal vein and the inferior vena
cava—are excluded. The total number of pixels within the
bounded area provides the cross-sectional area for a given
slice (Fig. 8b). Each slice area is then multiplied by the
slice thickness and the resulting volumes are summed to
provide the total liver volume. Similar inclusion and exclu-
sion parameters are used for in-painting, although in this
Fig. 5 Portal vein embolisation
prior to right hepatectomy. a
Axial enhanced CT image shows
colorectal liver metastasis
involving segments V, VI, VII
(only VII shown). b Final
portogram of embolised portal
vein branches in segments V
through VIII using a Lipiodol-
glue mixture. c Axial enhanced
CT image obtained 1 month after
right PVE showing hypertrophy
of future liver remnant. d Axial
enhanced CT image of the same
patient after right hepatectomy
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case the parenchyma is swept-over by the user to select
areas of interest within the liver [33].
There are many drawbacks of manual segmentation. There
is inherent intra-observer and inter-observer variability given
Fig. 6 Size incompatibility after living donor liver transplantation:
both the donor and the recipient suffered transient hepatic insufficiency.
a Axial enhanced CT image of a 26-year-old living liver donor. The total
liver volume (TLV) was 1,754 mL. The donated liver volume was
980 mL and the residual liver volume was 774 mL (44.2% of the TLV).
b Diagram showing the intended right split liver surgery planned for
living donor liver transplantation. c Post-liver transplantation axial
enhanced-CT image showing hypertrophied left liver of the donor. d
Post-liver transplantation axial enhanced-CT image of a 53-year-old
man who was the recipient of the right liver transplant. Although pre-
transplant volumetry calculations seemed to indicate that the liver size
was appropriate, the patient still developed small-for-size syndrome re-
quiring ligature of the splenic artery. The cause was likely multifactorial.
The donor developed transient biological hepatic insufficiency that re-
solved with supportive management
Fig. 7 Workflows of various segmentation strategies. The schematic
breaks down liver segmentation methods into truly manual, contour
optimisation, semi-automated, and fully automated workflows. Most
workflows require a combination of two-dimensional or three-
dimensional initialisation, refinement and editing techniques. VOI volume
of interest, MPR multi-planar reconstruction
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its subjectivity. Variability is also be introduced by the sharp-
ness of liver boundaries, window level settings, and computer
monitor settings [34]. Manual segmentation is also time-
consuming and may take up to 90 minutes for one patient
[35]. As a result, manual segmentation is not suited for a busy
clinical practice in high volume settings. Examples of assisted
contouring and in-painting techniques used during manual
segmentation are addressed below.
Assisted contouring
Active contours
In the active contour approach, the image analyst draws a
rough contour of the liver with the cursor. These contours,
also called snakes, are then tested with an interactive algo-
rithm that either forces the snake to collapse or expand based
on the data-set provided by the image. Ultimately, the contour
should snap to the outer borders of the liver (see Fig. 9 or the
supplementary material for an animation) For optimal seg-
mentation, the image must be adequately preprocessed and
the original contour must be close to the liver boundary.
This will prevent the algorithm from leaking into nearby or-
gans or falling into a local minimum. Of note, the active con-
tours technique is the basis for software SliceOmatic® created
by Tomovision [36].
Livewire
In the livewire approach the image is interpreted as a weighted
graph [37]. The pixels are represented by graph vertices.
Adjacent pixels are connected by graph edges; the cost of
connection between these vertices is represented by the weight
of these edges. The user clicks on the boundary to create a
Bseed point^ and the possible minimal cost pathways to all
other points on the image are calculated. Then, the user chooses
another boundary point, which is called the Bfree point^. The
boundary of the liver then behaves like a livewire, connecting
the seed point with the free point via a minimal cost path along
the liver edge (see Fig. 10 or the supplementary material for an
animation). The two-dimensional (2-D) livewire technique
serves as the basis for the software HepaVision® created by
MeVisLab [7, 13].
Shape interpolation
Shape interpolation allows the user to interpolate a complete
three-dimensional (3-D) shape by tracing a limited number of
contours. This reduces the number of images that must be
contoured to a few key slices. This technique can be combined
with the livewire approach to further optimise each of the
interpolated contours. This assisted contouring technique
serves as the basis for the 3-D deformable models technique,




SmartPaint employs a paintbrush paradigm. The user to
sweeps over the liver parenchyma and the algorithm selective-
ly sticks to certain regions, while avoiding others. This iden-
tifies the underlying voxels as belonging to either the object
(i.e. liver) or its background. The segmentation is updated in
real-time to provide immediate user feedback updating the
segmentation. Like with assisted contour techniques, once
all of the voxels belonging to the liver are accounted for, the
volume of the organ may be calculated [33].
Fig. 8 Manual segmentation of the liver. a Manual segmentation of the
liver performed by contouring of pixels of the liver boundary on CT
image. Image obtained using Osirix image post-processing software
(Osirix Foundation, Geneva, Switzerland). b Volume of the liver is ob-
tained based on pixel size and slice spacing [13]
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Semi-automated segmentation
Semi-automated segmentation techniques require coarse
initialisation from the user; the algorithm then provides the
majority of the optimisation. These techniques often rely on
a combination of interactions. Examples include intensity-
based techniques and graph cut.
Intensity-based techniques
Intensity-based techniques classify pixels and their neigh-
bours according to intensity or texture. For example, seeded
region growing is an intensity-based technique where Bseeds^
are positioned by the user in the liver parenchyma (see Fig. 11
or the supplementary material for an animation) [38]. The
pixels then iteratively aggregate if their intensity matches that
of those already tagged. As a result, intensity-based tech-
niques perform very well on homogenous livers. However,
since there is no shape control, intensity-based techniques
may result in leakage of the seeded area or rough edges.
This is particularly problematic in diseased livers where sub-
stantial user interaction may be required to achieve desired
results. Furthermore, intensity-based techniques are ill-suited
MR segmentation of the liver due to the greater heterogeneity
of the parenchyma on this modality [39].
Graph-cut
In the graph-cut technique, the user roughly paints some fore-
ground (i.e. the liver) and background pixels (i.e. peri-hepatic
structures). Based on graph analysis and optimisation, a cut is
then performed to separate the foreground and background
areas in the most homogeneous regions. This isolates the liver
on the given image slice for volumetry [40] (see supplemen-
tary material for an animation of this technique).
Fully automated segmentation
Fully automated segmentation techniques require no, or neg-
ligible, user input for typical datasets. However, they may
require manual adjustment for pathological or unusual cases.
Statistical shape models (SSMs)
Statistical shape models (SSMs) use global shape priors (i.e.
multiple geometric representations of the liver) to generate
segmentations that do not deviate from a reasonable liver
shape. This creates a hard constraint on liver morphology
from which the segmented liver is not permitted to deviate,
preventing segmentation leakage. Early studies used a single
global shape prior [41]; however, this had limited versatility,
Fig. 9 Active contours technique. a Image analyst roughly contours the liver using a cursor. b Contour evolves based on salient image features. c The
contour snaps to the true liver contour [13]
Fig. 10 Livewire technique. a User sets the Bseed point^ by clicking on the liver boundary. b As the cursor is moved, the boundary behaves like a
livewire, connecting the seed point to the cursor. c The free point is placed along the liver boundary, and a minimal cost path is generated [13]
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given the variability of liver shape among patients. SSMs
expand the range of admissible liver shapes [42]. In this ap-
proach, the image data is used to deform a surface mesh
parameterised by certain admissible shapes (Fig. 12).
Typically, about 30 shapes are used to establish the dataset.
SSMs offer an advantage over the previously discussed
segmentation techniques because of the precise modelling of
shape variations, which can be used to regularise the liver’s
appearance. This technique can produce accurate segmenta-
tion despite signal noise and retain robustness despite proxim-
ity of the liver to similarly appearing organs [43]. However,
SSM requires 30–75 segmented liver shapes to generate a
training dataset from which the main shape variations are de-
rived. Furthermore, the resulting model may be too
constraining if a patient’s liver shape is not adequately
represented in the training data. This may result in limited
application to pathological or post-operative livers.
3-D deformable models
A 3-D surface mesh of the liver may be iteratively deformed to
fit the liver boundaries by interpolating a surface between a
few sparse contours. This technique is based upon shape in-
terpolation, which was discussed in manual segmentation. For
each vertex of the generated mesh, matched features corre-
sponding to the liver boundary are identified in the patient
dataset. This mesh may then be subject to a non-rigid regis-
tration scheme [44], which deforms the shape towards the
liver boundary while preserving surface smoothness [35,
45]. If carefully tuned, a simple sphere can initiate the process.
Deformable models may also be derived completely indepen-
dently of user input (see BAdvanced segmentation^ below).
Pixel classification approaches
Awide range of segmentation techniques use quantitative im-
age texture features to train classification algorithms.
Examples include support vector machines (SVMs) [46] and
random forests [47]. Even though such features have a higher
discriminative power than the intensity based techniques, they
can lead to coarse segmentation and leakage. Recently,
convolutional neural networks were proposed in the setting
of liver segmentation, where quantitative features were
learned rather than being handcrafted. This technique allowed
for the segmentation of heterogeneous livers obtained using
different scanners and protocols in under 100 seconds [48].
Advanced segmentation techniques
The previously presented segmentation techniques are seldom
used on their own. Advanced segmentation strategies often
combine various segmentation techniques. For example, pixel
classification can be combined with graph-cut optimisation,
SSM [47] or probabilistic models [49, 50] for robust automat-
ed segmentation. SSM may also be used as a robust
Fig. 11 Seeded region-growing technique. a Seeds are positioned inside the regions of interest by user. b Pixels are iteratively aggregated if their
intensity is similar to those already tagged. c The liver parenchyma is segmented
Fig. 12 Statistical shape models. To restrict the segmentation to a set of
admissible liver shapes, a shape database is compiled, from which any
new liver shape is expressed by a set of parameters called modes of
variation. The various modes of variation (roughly 30 modes) are
adjusted to fit the liver shape on image features. Statistical shape
models impose hard restriction on the segmentation outcome by
integrating prior shape. However, training data cannot capture all
variations and therefore are sometimes too limiting to accurately model
specific livers [13]
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initialisation phase in combination with a 3-D deformable
model to better account for the natural heterogeneity between
and within livers [51].
Summary
A summary of the advantages and disadvantages of various
segmentation techniques illustrated in the previous sections is
provided in Table 1.
Alternatives to liver segmentation for volumetry
Alternative methods of volumetric analysis, such as stereolo-
gy, merit mention. Stereology is a volumetric technique that
employs statistical methods to calculate liver volume, where-
by a sample of pixels is selected on individual liver slices to
calculate the entire liver volume. This sample can be taken
using a variety of methods, such as grid-based sampling meth-
od (the Cavalieri method). In this method, a regular grid is
placed over cross-sectional images; each time the liver
touches a pre-selected structure (e.g. right lower corner of a
square), it is counted in the volumetric calculation [52]. The
calculated cross-sectional area is then summed across slices to
calculate the volume [53]. Advantages of such a method in-
clude speed, cost-effectiveness, multimodal applicability (CT,
MRI, ultrasound) and the ability to perform subsegmentation
(lesions, vascular structures, specific liver segments) [52]; dis-
advantages may include variation based on slice thickness and
slightly decreased accuracy [53].
Imaging requirements
Liver segmentation methods can generally be applied to any
modality, sequence or vascular phase. The success of a given
technique, however, depends upon the quality of implemen-
tation, which is the extent to which the technique has been
trained to initiate and regularise segmentation for a given im-
age type. This depends not only on the technique itself but also
on the appearance model used in the study. The appearance
model (i.e. what the technique classifies as liver) must be well
adapted for the modality, sequence, and vascular phase to
discern liver tissue from adjacent structures for optimal
segmentation.
CT is generally preferred over MRI for segmentation be-
cause of higher spatial resolution, isotropic voxels, robustness
(does not require long breath-holds) and calibrated Hounsfield
units (whereas MRI provides arbitrary signal intensity). The
portal venous phase also tends to be popular as it enhances the
liver parenchyma.
For MRI, the contrast agents gadoxetate disodium
(Primovist, Eovist; Bayer Healthcare, Leverkusen, Germany)
and gadobenate dimeglumine (MultiHance; Bracco
Diagnostic, Milan, Italy) can help improve liver segmentation.
Table 1 Summary of advantages and limitations of various segmentation methods [13]




















↑↑ ↓↓ ↓↓ ↓↓ ↑↑
Note: Green cells indicate desirable features, whereas red cells indicate limitations. One arrow indicates a minor feature, whereas two arrows indicate a
major feature. The direction of the arrow refers to increase or decrease in the specific parameter.
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Both are gadolinium-based contrast agents that provide
hepatobiliary phases during MRI occurring 20 minutes
and 2 hours after contrast injection [54]. Imaging in
the hepatobiliary phase reveals strong uptake in the nor-
mal liver, which may accentuate the contrast with non-
hepatic tissue (e.g. vessels or focal liver lesions) and
adjacent organs. The hepatobiliary uptake is roughly
50% of the injected dose of gadoxetate disodium and
5% of the injected dose of gadobenate dimeglumine
[55]. The hepatospecificity of gadoxetate disodium in-
creases the contrast between liver parenchyma and liver
lesions or vascular structures compared to conventional
contrast agents and other imaging modalities [54, 56,
57].
The increased contrast with gadoxetate disodium-
enhanced MRI has been exploited for liver segmentation
purposes. For example, Grieser et al. [58] showed that liver
segmentation of Gd-EOB-enhanced T1-weighted 3-D
gradient-recalled-echo images using threshold-based tech-
niques are both accurate and time-saving. The authors
showed that the performance of this approach can be fur-
ther improved by increasing flip angle. Fernandez-de-
Manuel et al. [59] proposed a multimodal non-rigid regis-
tration framework combining gadoxetic acid-enhanced
MRI and contrast-enhanced CT images to characterise liv-
er lesions. Despite these benefits, these contrast agents will
not likely take the place of the portal venous phase due to
the latter ’s specificity and utility for overall liver
volumetry and vascular subsegmentation [59].
Segmentation pitfalls
There are several sources of error that must be accounted for
during the usage of automated segmentation techniques. The
following section outlines sources of error associated with
imaging modality and patient anatomy.
Error linked to modality
The imaging modality used for segmentation has a di-
rect impact on the quality of the features extracted from
the images. With poorer feature extraction comes a
higher risk of segmentation error and divergence.
Specific acquisition parameters and imaging artefacts
can affect segmentation results and represent potential
sources of error.
Breath-holding can be used during both CT and MRI to
limit the effects of respiratory motion on the quality of images.
CT is less affected by motion due to rapid acquisition times.
MRI requires longer acquisition times to achieve adequate
spatial resolution and signal-to-noise ratio. Slice thickness
can be increased to improve z-axis coverage in patients with
limited breath-holding capacities. However, this results in par-
tial volume effects when the voxels at the interface of two
structures with varying signal characteristics must be aver-
aged. In addition, the large spaces between voxels must also
be interpolated, increasing volumetric error.
Slice thickness impacts liver volumetry results [30, 53, 60].
In general, thinner slices tend to be more accurate for estima-
tion of liver volume using MRI [53]. Reiner et al. [60] sug-
gested that 8-mm slices on MRI and 6-mm slices on CT pro-
vided the best compromise between volumetric precision and
efficiency.
CT and MRI are both subject to artefacts. Metallic ob-
jects—such as surgical clips—cause streak artefacts on CT
and susceptibility artefacts on MRI, which may both cause
segmentation error. Other artefacts, such as motion, pulsation
and partial volume averaging artefacts, may also interfere with
segmentation accuracy [30, 61]. Figure 13 illustrates artefacts
and imaging pitfalls commonly seen on MRI.
Error linked to anatomy
Normal and abnormal anatomical features may cause segmen-
tation error. On CT, segmentation error often occurs at the
interface of the liver parenchyma with the stomach, intercostal
muscles, diaphragm, spleen and heart (Fig. 14). Error on CT
and MRI may occur at low-contrast borders, adjacent to tu-
mours, near vascular insertions and at the hepatic flexure [43].
Over-segmentation tends to occur at peri-hepatic organs,
whereas under-segmentation tends to occur in areas of inho-
mogeneous density and at low-contrast liver boundaries [61].
Liver pathology—including steatosis, cirrhosis, malignancies,
areas of ablation and polycystic disease—may distort the liver
and cause an irregular or lobulated morphology which may
also interfere with automated segmentation processes. These
errors can be overcome with increased user interaction, either
during the initialisation phase or with interactive correction
tools.
Emerging surgical needs and future directions
Vascular subsegmentation
As previously mentioned, the standard Couinaud classifica-
tion system does not take into account the numerous anatom-
ical liver variants encountered in individual patients. In the
near future, liver subsegmentation may be performed regular-
ly according to vascular supply (i.e. portal veins and hepatic
arteries) or drainage (i.e. hepatic veins) (Fig. 15). Such seg-
mentation will provide surgeons crucial information regarding
anatomical variants prior to hepatectomy or transplant.
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Surgical planning
Commercially available segmentation solutions may provide
virtual surgical simulation tools for hepatectomy or transplant.
Using the segmentation techniques previously discussed,
these solutions can integrate parenchymal and vascular seg-
mentation tools for 3-D modelling (Fig. 16). These techniques
can also be used to model lesions to exclude them from vol-
umetric analysis. In general, semi-automated techniques are
more successful in allowing the user to include or exclude the
lesion based on the clinical context, as lesions are unknown
components that are difficult to account for in the training data
used to develop fully automated techniques.
The Supplementary Table provides a non-exhaustive list of
commercially available liver segmentation software and solu-
tions that can be used for volumetry and 3-Dmodelling. These
software solutions employ various semi-automated and auto-
mated segmentation techniques in combination with the abil-
ity to perform manual corrections. For each software solution,
we have provided the following information: manufacturer,
operating system supported, segmentation techniques
employed, modalities supported, sequences or vascular phases
Fig. 13 Imaging pitfalls which
may degrade liver segmentation
on MRI. Axial T1-weighted fat-
saturated images with contrast in-
jection depict the following arte-
facts: a Severe motion artefact. b
Partial volume averaging of the
liver parenchyma with the gall-
bladder (arrows). c Ghost artefact
with the aorta (arrow). d
Inhomogeneous fat saturation
(white arrows) and fat-water swap
in the liver (arrowheads) [13]
Fig. 14 Imaging pitfalls which may limit liver segmentation on CT. a
Axial enhanced CT image of a 62-year-old woman shows indistinct liver-
spleen boundaries (arrows). bAxial enhanced CT image of a 47-year-old
man depicts segmentation challenges caused by ill-defined and non-
continuous borders found near the liver dome (arrows). cAxial enhanced
CT image of a 73-year-old man shows partial volume averaging between
the left liver and the heart (arrows) [13]
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recommended, ability to perform subsegmentation, PACS in-
tegration, and a web page reference.
In addition, liver segmentation and surgical planning ser-
vices are offered by private companies according to a fee-for-
service model. Anonymised datasets are uploaded to a website
and segmentation results are returned with 3-D models that
may be viewed on a website, in a dynamic document, or within
a dedicated software viewer for simulation of surgical scenari-
os. An example can be found in the Supplementary Table.
MRI-based biomarkers
Imaging-based biomarkers have recently been introduced for
quantification of diffuse liver disease. MRI-determined proton
Fig. 16 Virtual surgical
planning. a Axial enhanced CT
image shows a right liver
metastasis centred in segment V
(arrow). The patient also had a
metastasis involving segment VII
(not shown). b Axial enhanced
CT image of a different patient
shows a left liver metastasis in
segment III (arrow). c Three-
dimensional rendering image
shows surgical planning for com-
plete right hepatectomy including
tumour and hepatic structures in
patient from a. d Three-
dimensional rendered image
shows surgical planning for
segmentectomy of segment III for
patient in b. Residual hepatic liver
volume after both procedures was
estimated to be 27%. Right portal
embolisation was thus performed
before right hepatectomy.




Fig. 15 Liver subsegmentation according to vascular anatomy. Axial
enhanced CT showing the segmented a hepatic arterial, b portal venous
and c hepatic venous structures. Three-dimensional rendering of the same
liver showing the corresponding segmented d arterial, e portal venous and
f hepatic venous structures [13]
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density fat fraction (PDFF) [62–64] has become an alternative
to liver biopsy for estimation of liver fat content [62] and
produces parametric maps of fat distribution throughout the
liver [65]. The product of the average PDFF and the segment-
ed liver volume produces the total liver fat index (TLFI), a
novel biomarker of total fat burden in non-alcoholic
steatohepatitis. TLFI has been shown to accurately monitor
liver fat burden over time in the setting of a clinical trial
[66]. Other volume averaged biomarkers in liver disease, such
as iron per unit volume, are also being investigated. Further
studies may incorporate other volume averaged biomarkers in
liver disease [67].
Impact of liver quality
While the bulk of this review has focused on the determination
of liver volume—which directly impacts procedural plan-
ning—liver quality is an important, and interrelated, parame-
ter. As alluded to in the section BIndications for liver
volumetry ,̂ the optimal ratio of FLR to TLV varies depending
on the degree of liver pathology; higher FLR to TLV ratios are
required in those with moderately diseased livers (i.e. liver
steatosis secondary to chemotherapy, obesity or type 2 diabe-
tes mellitus) and cirrhosis compared to normal prior to hepa-
tectomy [17, 68].
Liver quality has an impact on liver segmentation as well.
For example, fatty liver secondary to chemotherapy appears
less dense, which may make hypovascular liver metastases
more difficult to detect [69]. In the setting of cirrhosis, animal
studies have demonstrated reduced uptake of gadoxetate
disodium related to reduced expression of organic anion-
transporting polypeptides [69, 70]. Clinically, an increase in
hepatobiliary phase enhancement ratios has been observed in
patients with Child-Pugh A disease compared to Child-Pugh
C disease [71]. Thus, the benefit of liver uptake of
hepatobiliary contrast agents in segmentation may be de-
creased with advancing liver disease. Increasing the dose of
contrast agent or increasing the flip angle in these patients may
help compensate for lower liver signal [72].
Conclusions
Liver volumetry is a common application of liver segmenta-
tion. Liver volumetry is indicated in procedural planning for
hepatectomy, PVE, ALPPS and liver transplant. Liver seg-
mentation can be performed manually or with the assistance
of semi-automated or fully automated algorithms of both CT
and MR images. Future studies will be directed at addressing
segmentation pitfalls, incorporating patient-specific
subsegmentation and 3-D modelling into clinical decision
making, the use of novel contrast agents and the combination
of liver volumetry with MRI-based biomarkers.
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